![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Sustained Viral Response and Safety of Vaniprevir (MK-7009) in Cirrhotic, Treatment-Experienced Patients with Genotype 1 HCV Infection Who Have Failed Previous Pegylated Interferon and Ribavirin
|
|
|
Reported by Jules Levin
The 48th Annual Meeting of the European Association for Study of The Liver
Amsterdam, The Netherlands, April 24-28, 2013
Maribel Rodriguez-Torres, Albrecht Stoehr, Edward Gane, Lawrence Serfaty, Eric Lawitz, Michael Bourque, Sanhita Bhanja, Richard Barnard, Peggy Hwang, Niloufar Mobashery
![EASL1.gif](../images/050613/050613-5/EASL1.gif)
![EASL2.gif](../images/050613/050613-5/EASL2.gif)
![EASL3.gif](../images/050613/050613-5/EASL3.gif)
![EASL4.gif](../images/050613/050613-5/EASL4.gif)
![EASL5.gif](../images/050613/050613-5/EASL5.gif)
![EASL6.gif](../images/050613/050613-5/EASL6.gif)
![EASL7.gif](../images/050613/050613-5/EASL7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|